Fibrosis driving myofibroblast precursors in MPN and new therapeutic pathways
Main Authors: | Hélène F.E. Gleitz, Jessica E. Pritchard, Rafael Kramann, Rebekka K. Schneider |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000216 |
Similar Items
-
Platelet-instructed SPP1+ macrophages drive myofibroblast activation in fibrosis in a CXCL4-dependent manner
by: Konrad Hoeft, et al.
Published: (2023-02-01) -
COVID-19 Infection May Drive EC-like Myofibroblasts towards Myofibroblasts to Contribute to Pulmonary Fibrosis
by: Xiuju Wu, et al.
Published: (2023-07-01) -
S205: INHIBITING THE ALARMIN-DRIVEN HEMATOPOIESIS-STROMAL CELLS CROSSTALK IN PRIMARY MYELOFIBROSIS AMELIORATES BONE MARROW FIBROSIS
by: Hélène Gleitz, et al.
Published: (2023-08-01) -
Myofibroblast-derived exosomes enhance macrophages to myofibroblasts transition and kidney fibrosis
by: Wenqiang Yu, et al.
Published: (2024-12-01) -
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
by: Julian Baumeister, et al.
Published: (2021-12-01)